Treatment demonstrated positive outcomes for nearly five years
Companies will develop ultra-small implantable medical devices
Treatment is approved for relapsed/refractory multiple myeloma
Updated Date: Fri, 09 Oct 2020 00:00:00 EDT
Updated Date: Fri, 09 Oct 2020 00:00:00 EDT
More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are […]
A rapid and simple method for testing the efficacy of antibacterial drugs on infectious microbes has been developed […]
England’s test and trace system has recorded its worst weekly performance since it launched in May, official figures1 […]
No need to panic about COVID trial halts, FDA chief says. They show the system is working esagonowsky […]
3M spinoff Kindeva Drug Delivery plots new Minnesota operations center fkansteiner Thu, 10/15/2020 – 09:50